Author
Listed:
- Wenfan Ke
(University of Virginia)
- James A. Saba
(University of Virginia)
- Cong-Hui Yao
(Washington University)
- Michael A. Hilzendeger
(University of Virginia)
- Anna Drangowska-Way
(University of Virginia)
- Chintan Joshi
(University of California, San Diego
University of California, San Diego)
- Vinod K. Mony
(University of Virginia)
- Shawna B. Benjamin
(University of Virginia)
- Sisi Zhang
(Washington University)
- Jason Locasale
(Duke University)
- Gary J. Patti
(Washington University)
- Nathan Lewis
(University of California, San Diego
University of California, San Diego)
- Eyleen J. O’Rourke
(University of Virginia
University of Virginia)
Abstract
The gut microbiota metabolizes drugs and alters their efficacy and toxicity. Diet alters drugs, the metabolism of the microbiota, and the host. However, whether diet-triggered metabolic changes in the microbiota can alter drug responses in the host has been largely unexplored. Here we show that dietary thymidine and serine enhance 5-fluoro 2′deoxyuridine (FUdR) toxicity in C. elegans through different microbial mechanisms. Thymidine promotes microbial conversion of the prodrug FUdR into toxic 5-fluorouridine-5′-monophosphate (FUMP), leading to enhanced host death associated with mitochondrial RNA and DNA depletion, and lethal activation of autophagy. By contrast, serine does not alter FUdR metabolism. Instead, serine alters E. coli’s 1C-metabolism, reduces the provision of nucleotides to the host, and exacerbates DNA toxicity and host death without mitochondrial RNA or DNA depletion; moreover, autophagy promotes survival in this condition. This work implies that diet-microbe interactions can alter the host response to drugs without altering the drug or the host.
Suggested Citation
Wenfan Ke & James A. Saba & Cong-Hui Yao & Michael A. Hilzendeger & Anna Drangowska-Way & Chintan Joshi & Vinod K. Mony & Shawna B. Benjamin & Sisi Zhang & Jason Locasale & Gary J. Patti & Nathan Lewi, 2020.
"Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion,"
Nature Communications, Nature, vol. 11(1), pages 1-19, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16220-w
DOI: 10.1038/s41467-020-16220-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16220-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.